Meda Pension Equity Plan
ERISA Form 5500 plan record drawn from DOL EBSA — verify with linked source filings below.
Sponsored by Meda Pharmaceuticals Inc. · Pennsylvania · Manufacturing
What the 2023 filing shows
Meda Pension Equity Plan holds $58M for 5 participants - about $11.7M per participant, down 20.7% over the 2022 plan year.
- $58M
- total plan assets (2022 EOY)
- 5
- covered participants
- $11.7M
- avg assets per participant
- -20.7%
- assets change YoY
The plan reported a net loss of $15M for the year — a single-year figure driven by markets and benefit payments, not a measure of plan health.
What the Filing Says About Meda Pension Equity Plan
Meda Pension Equity Plan is a Other retirement plan sponsored by Meda Pharmaceuticals Inc., headquartered in Pennsylvania. As of the 2022 Form 5500 filing, the plan reports $58M in total end-of-year assets and covers 5 participants across the Manufacturing industry. The sponsor's EIN on file with the U.S. Department of Labor is 134986583, and the plan has been effective since 1960-04-01. Its filing status is currently FILING RECEIVED.
Year over year, total assets moved from $74M at the beginning of 2022 to $58M at year-end — a decline of 20.7%. Net assets (after liabilities) closed the year at $58M, with reported net income of $-15,215,546 driven by investment returns, contributions received, and benefit payments during the period. These figures reflect what the plan administrator certified on Schedule H or Schedule I of the Form 5500 annual return and can be compared against 2 prior plan-year filings from the same sponsor shown below.
Asset totals and participant counts reflect a single plan year snapshot and can change materially with market conditions, plan mergers, or workforce changes. Fields such as "net income" include both realized investment performance and contribution/distribution flows — a single-year figure does not by itself indicate plan health or participant outcomes. This page summarizes public DOL disclosures for research and educational purposes only and is not retirement, tax, legal, or financial advice. Before making decisions about your own retirement benefits or evaluating an employer's plan, verify the underlying filing directly via the DOL EFAST2 system and consult a qualified professional.
Financial Summary (2023)
| Total Assets (Beginning of Year) | $74M |
| Total Assets (End of Year) | $58M |
| Net Assets (End of Year) | $58M |
| Net Income | $-15,215,546 |
| Plan Type | Other |
| Employer EIN | 134986583 |
| Plan Effective Date | 1960-04-01 |
| Filing Status | FILING RECEIVED |
Sponsor Plan History (Meda Pharmaceuticals Inc.)
| Year | Plans | Participants | Total Assets |
|---|---|---|---|
| 2022 | 1 | 5 | $58M |
| 2023 | 1 | 5 | $67M |
| 2024 | 1 | 17 | $62M |
Nearby Other Plans in Pennsylvania
Peer Other plans — same state, same plan type — ranked by total assets.
- National Elevator Industry Pension Plan $11.2B · 27,434
- Wawa, Inc. Employee Stock Ownership Plan $5.3B · 42,695
- Eastern Atlantic States Carpenters Pension Fund $4.7B · 11,775
- The University of Pennsylvania Health System 403(b) Retirement Savings Plan $3.1B · 41,942
- Glaxosmithkline Cash Balance Pension Plan $2.9B · 8,441
Related Data
Guides
Frequently Asked Questions
How much money is in the Meda Pension Equity Plan? ▼
What type of plan is Meda Pension Equity Plan? ▼
Who sponsors the Meda Pension Equity Plan? ▼
How did Meda Pension Equity Plan perform in 2022? ▼
Where can I find official filings for Meda Pension Equity Plan? ▼
How does Meda Pension Equity Plan compare to other plans? ▼
Explore PlainRetire
Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2022.
Source: DOL EFAST2 filing system (efast.dol.gov) — original filing retrieval by EIN 134986583.
Reference: IRS Publication 560 — Retirement Plans for Small Business, contribution-limit rules.
Reference: IRS Publication 590-B — Distributions from IRAs, RMD rules under SECURE Act 2.0.
Read our methodology — how this data is sourced, computed, and verified.